Skip to main content
Top
Published in: Diabetologia 12/2014

01-12-2014 | Article

Association of physical activity with lower type 2 diabetes incidence is weaker among individuals at high genetic risk

Authors: Yann C. Klimentidis, Zhao Chen, Amit Arora, Chiu-Hsieh Hsu

Published in: Diabetologia | Issue 12/2014

Login to get access

Abstract

Aims/hypothesis

We examined whether or not the association of physical activity with type 2 diabetes incidence differs according to several types of genetic susceptibility.

Methods

In a large prospective cohort with 821 incident cases of type 2 diabetes, we examined interactions of physical activity with: (1) each of 65 type 2 diabetes-associated single nucleotide polymorphisms (SNPs); (2) a genetic risk score (GRS) comprising all 65 SNPs; (3) two GRSs comprised of SNPs implicated in insulin resistance (IR) and insulin secretion; (4) GRSs for fasting insulin (FI) and fasting glucose.

Results

We found a significant interaction of physical activity and the type 2 diabetes GRS (p interaction = 0.016), suggesting a weaker protective effect of physical activity in those at high genetic risk. Based on the interactions observed with the IR GRS (p interaction = 0.046) and the FI GRS (p interaction = 0.042), it appears that the overall type 2 diabetes GRS interaction most likely occurs through genetic susceptibility to IR as opposed to insulin secretion. Furthermore, this interaction was more pronounced in women (p interaction = 0.0025) than in men (p interaction = 0.46). No single SNP stood out as displaying a strong interaction with physical activity.

Conclusions/interpretation

We conclude that although physical activity appears to have an overall protective effect on type 2 diabetes, this putative effect is weakest among individuals with high genetic risk for type 2 diabetes and IR.
Appendix
Available only for authorised users
Literature
1.
go back to reference Sigal RJ, Kenny GP, Wasserman DH et al (2006) Physical activity/exercise and type 2 diabetes: a consensus statement from the American Diabetes Association. Diabetes Care 29:1433–1438PubMedCrossRef Sigal RJ, Kenny GP, Wasserman DH et al (2006) Physical activity/exercise and type 2 diabetes: a consensus statement from the American Diabetes Association. Diabetes Care 29:1433–1438PubMedCrossRef
2.
go back to reference Nelson TL, Fingerlin TE, Moss LK et al (2007) Association of the peroxisome proliferator-activated receptor gamma gene with type 2 diabetes mellitus varies by physical activity among non-Hispanic whites from Colorado. Metabolism 56:388–393PubMedCrossRef Nelson TL, Fingerlin TE, Moss LK et al (2007) Association of the peroxisome proliferator-activated receptor gamma gene with type 2 diabetes mellitus varies by physical activity among non-Hispanic whites from Colorado. Metabolism 56:388–393PubMedCrossRef
3.
go back to reference Kilpeläinen TO, Lakka TA, Laaksonen DE et al (2007) Physical activity modifies the effect of SNPs in the SLC2A2 (GLUT2) and ABCC8 (SUR1) genes on the risk of developing type 2 diabetes. Physiol Genomics 31:264–272PubMedCrossRef Kilpeläinen TO, Lakka TA, Laaksonen DE et al (2007) Physical activity modifies the effect of SNPs in the SLC2A2 (GLUT2) and ABCC8 (SUR1) genes on the risk of developing type 2 diabetes. Physiol Genomics 31:264–272PubMedCrossRef
4.
go back to reference Brito EC, Lyssenko V, Renström F et al (2009) Previously associated type 2 diabetes variants may interact with physical activity to modify the risk of impaired glucose regulation and type 2 diabetes. Diabetes 58:1411–1418PubMedCentralPubMedCrossRef Brito EC, Lyssenko V, Renström F et al (2009) Previously associated type 2 diabetes variants may interact with physical activity to modify the risk of impaired glucose regulation and type 2 diabetes. Diabetes 58:1411–1418PubMedCentralPubMedCrossRef
5.
go back to reference Morris AP, Voight BF, Teslovich TM et al (2012) Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nat Genet 44:981–990PubMedCentralPubMedCrossRef Morris AP, Voight BF, Teslovich TM et al (2012) Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nat Genet 44:981–990PubMedCentralPubMedCrossRef
6.
go back to reference Florez JC (2008) Newly identified loci highlight beta cell dysfunction as a key cause of type 2 diabetes: where are the insulin resistance genes? Diabetologia 51:1100–1110PubMedCrossRef Florez JC (2008) Newly identified loci highlight beta cell dysfunction as a key cause of type 2 diabetes: where are the insulin resistance genes? Diabetologia 51:1100–1110PubMedCrossRef
7.
go back to reference Dimas AS, Lagou V, Barker A et al (2014) Impact of type 2 diabetes susceptibility variants on quantitative glycemic traits reveals mechanistic heterogeneity. Diabetes 63:2158–2171PubMedCrossRef Dimas AS, Lagou V, Barker A et al (2014) Impact of type 2 diabetes susceptibility variants on quantitative glycemic traits reveals mechanistic heterogeneity. Diabetes 63:2158–2171PubMedCrossRef
8.
go back to reference Segal KR, Edano A, Abalos A et al (1991) Effect of exercise training on insulin sensitivity and glucose metabolism in lean, obese, and diabetic men. J Appl Physiol 71:2402–2411PubMed Segal KR, Edano A, Abalos A et al (1991) Effect of exercise training on insulin sensitivity and glucose metabolism in lean, obese, and diabetic men. J Appl Physiol 71:2402–2411PubMed
9.
go back to reference The Aric Investigators (1989) The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators. Am J Epidemiol 129:687–702 The Aric Investigators (1989) The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators. Am J Epidemiol 129:687–702
10.
go back to reference Duncan BB, Schmidt MI, Pankow JS et al (2003) Low-grade systemic inflammation and the development of type 2 diabetes: the atherosclerosis risk in communities study. Diabetes 52:1799–1805PubMedCrossRef Duncan BB, Schmidt MI, Pankow JS et al (2003) Low-grade systemic inflammation and the development of type 2 diabetes: the atherosclerosis risk in communities study. Diabetes 52:1799–1805PubMedCrossRef
11.
go back to reference Baecke JA, Burema J, Frijters JE (1982) A short questionnaire for the measurement of habitual physical activity in epidemiological studies. Am J Clin Nutr 36:936–942PubMed Baecke JA, Burema J, Frijters JE (1982) A short questionnaire for the measurement of habitual physical activity in epidemiological studies. Am J Clin Nutr 36:936–942PubMed
12.
go back to reference Folsom AR, Arnett DK, Hutchinson RG et al (1997) Physical activity and incidence of coronary heart disease in middle-aged women and men. Med Sci Sports Exerc 29:901–909PubMedCrossRef Folsom AR, Arnett DK, Hutchinson RG et al (1997) Physical activity and incidence of coronary heart disease in middle-aged women and men. Med Sci Sports Exerc 29:901–909PubMedCrossRef
13.
go back to reference Diez-Roux AV, Nieto FJ, Caulfield L et al (1999) Neighbourhood differences in diet: the Atherosclerosis Risk in Communities (ARIC) Study. J Epidemiol Community Health 53:55–63PubMedCentralPubMedCrossRef Diez-Roux AV, Nieto FJ, Caulfield L et al (1999) Neighbourhood differences in diet: the Atherosclerosis Risk in Communities (ARIC) Study. J Epidemiol Community Health 53:55–63PubMedCentralPubMedCrossRef
14.
go back to reference Scott R, Lagou V, Welch RP et al (2012) Large-scale association analyses identify new loci influencing glycemic traits and provide insight into the underlying biological pathways. Nat Genet 44:991–1005PubMedCentralPubMedCrossRef Scott R, Lagou V, Welch RP et al (2012) Large-scale association analyses identify new loci influencing glycemic traits and provide insight into the underlying biological pathways. Nat Genet 44:991–1005PubMedCentralPubMedCrossRef
15.
go back to reference Howie B, Marchini J, Stephens M, Chakravarti A (2011) Genotype imputation with thousands of genomes. G3 (Bethesda) 1:457–470CrossRef Howie B, Marchini J, Stephens M, Chakravarti A (2011) Genotype imputation with thousands of genomes. G3 (Bethesda) 1:457–470CrossRef
16.
go back to reference Team RDC (2011) R: a language and environment for statistical computing. Team RDC (2011) R: a language and environment for statistical computing.
17.
go back to reference Kilpeläinen TO, Qi L, Brage S et al (2011) Physical activity attenuates the influence of FTO variants on obesity risk: a meta-analysis of 218,166 adults and 19,268 children. PLoS Med 8:e1001116PubMedCentralPubMedCrossRef Kilpeläinen TO, Qi L, Brage S et al (2011) Physical activity attenuates the influence of FTO variants on obesity risk: a meta-analysis of 218,166 adults and 19,268 children. PLoS Med 8:e1001116PubMedCentralPubMedCrossRef
18.
go back to reference Li S, Zhao JH, Luan J et al (2010) Physical activity attenuates the genetic predisposition to obesity in 20,000 men and women from EPIC-Norfolk prospective population study. PLoS Med 7:e1000332PubMedCentralPubMedCrossRef Li S, Zhao JH, Luan J et al (2010) Physical activity attenuates the genetic predisposition to obesity in 20,000 men and women from EPIC-Norfolk prospective population study. PLoS Med 7:e1000332PubMedCentralPubMedCrossRef
19.
go back to reference Ahmad S, Rukh G, Varga TV et al (2013) Gene × physical activity interactions in obesity: combined analysis of 111,421 individuals of European ancestry. PLoS Genet 9:e1003607PubMedCentralPubMedCrossRef Ahmad S, Rukh G, Varga TV et al (2013) Gene × physical activity interactions in obesity: combined analysis of 111,421 individuals of European ancestry. PLoS Genet 9:e1003607PubMedCentralPubMedCrossRef
20.
go back to reference Langenberg C, Sharp SJ, Franks PW et al (2014) Gene-lifestyle interaction and type 2 diabetes: the EPIC interact case-cohort study. PLoS Med 11:e1001647PubMedCentralPubMedCrossRef Langenberg C, Sharp SJ, Franks PW et al (2014) Gene-lifestyle interaction and type 2 diabetes: the EPIC interact case-cohort study. PLoS Med 11:e1001647PubMedCentralPubMedCrossRef
Metadata
Title
Association of physical activity with lower type 2 diabetes incidence is weaker among individuals at high genetic risk
Authors
Yann C. Klimentidis
Zhao Chen
Amit Arora
Chiu-Hsieh Hsu
Publication date
01-12-2014
Publisher
Springer Berlin Heidelberg
Published in
Diabetologia / Issue 12/2014
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-014-3380-z

Other articles of this Issue 12/2014

Diabetologia 12/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.